Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Wellorithm at a Glance
- What it is
- Advertises an 18% average weight loss and that 93% "kept the weight off for good" on six months of its own data — and lists a German address while calling itself Miami-based
- Medication type
- Brand-name and compounded
- Medications offered
- Compounded semaglutide injection and oral dissolving tablets
- Compounded tirzepatide injection and oral dissolving tablets
- Brand-name Wegovy, Ozempic, Mounjaro and Zepbound
- Sermorelin and NAD+
- Pricing
- Compounded from $147/mo semaglutide and $249/mo tirzepatide; brand-name $899–$1,399/mo
- Insurance
- Not accepted. Wellorithm is cash-pay only, and its Terms say so. Given that it sells brand-name Wegovy at $899 and Mounjaro at $1,399, anyone with potential coverage should look elsewhere first.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Wellorithm?
Wellorithm is a cash-pay telehealth service selling compounded and brand-name GLP-1s in all 50 states, with a two-minute online quiz, no video visit, and medication shipped to your door. Compounded semaglutide starts at $147/month and compounded tirzepatide at $249, each advertised with $100 off the first month.
We have reviewed more than eighty providers in this market and this is among the small number we would tell a reader to walk away from. The reason is not the pricing. It is that the claims on its own landing page do not survive contact with the numbers behind them.
Wellorithm advertises that patients "Lose an average of 18% of your body weight", that "93% kept the weight off for good", that its programme delivers "6x more weight loss than exercise and diet alone", and that "9/10 Patients call it the most effective treatment to date". The single footnote reads: "Data based on Wellorithm patients over their first 6 months of treatment." You cannot establish that anyone kept weight off "for good" from six months of observation — the claim and its stated evidence base contradict each other on the same screen. Its patient cards go further, attributing "17% increased muscle" to one patient, which runs against the well-documented finding that GLP-1 treatment causes loss of lean mass rather than gain.
Then there is the question of where the company is. Its Terms and Conditions and its Privacy Policy both describe Wellorithm as "a Miami-based company". The footer of every page on the site gives an address in Germany: "785 15h Street, Office 478, Berlin, De 81566". That postcode belongs to Munich rather than Berlin, and the street name is malformed. Governing law under the Terms is New York. Three jurisdictions, no verifiable address, for a company handling prescriptions and health data.
How the Program Works
- Consultation process
- A "2-minute quiz to get approved effortlessly", reviewed by what Wellorithm describes as licensed professionals who "provide approval in no time". No video visit. We could find no named physician, medical director or medical group anywhere on the site.
- Eligibility
- Not published as criteria. The site presents a weight-loss calculator instead — enter 200 lb and it returns a "Weight loss potential" of 46 lb, or 23% of body weight, which exceeds the average result in the pivotal trials of either approved drug.
- Provider involvement
- "Licensed doctors across the United States" and "unlimited appointments, messaging and support" with 24/7 access are advertised. Nobody is named. The Terms state that the platform "functions as a facilitator, not a medical provider".
- Lab requirements
- Not published. Nothing on the site states whether bloodwork is required, included, or available.
- Pharmacy fulfillment
- Not disclosed. No compounding pharmacy is named and no 503A or 503B designation appears anywhere. To its credit, the homepage does carry the disclosure that "Compounded medications have not been reviewed or approved by the FDA".
- Shipping frequency
- Free shipping is advertised, with a monthly shipment of compounded medication under the membership. Membership fees are billed every 28 days rather than monthly.
- Support services
- Unlimited appointments, messaging and 24/7 specialist access are advertised, along with a phone line.
Wellorithm Pricing
- Membership fee
- The homepage says "No membership or hidden fees!". The Terms and Conditions describe a membership billed every 28 days that includes clinical access and a monthly medication shipment. Those two statements are not compatible, and 28-day billing means thirteen charges a year, not twelve.
- Medication fee
- Compounded semaglutide injection or ODT from $147/month and compounded tirzepatide injection or ODT from $249/month, each advertised as "$100 off your first month" — so the advertised figure is the discounted one, not the ongoing rate. Brand-name: Wegovy $899, Ozempic $1,199, Zepbound $1,199, Mounjaro $1,399. NAD+ and sermorelin from $150.
- Cancellation policy
- You can cancel at any time by email under the Terms, but the current billing cycle is not refunded. Reinstatement is possible by contacting support. Wellorithm also reserves the right to modify or discontinue the programme at its discretion on 30 days' notice.
- Refund policy
- The Terms state plainly that "payments are non-refundable once processed". The one exception is the weight-loss guarantee, and that is more specific than the marketing suggests: if you do not lose at least 10% of your baseline weight after 16 weeks of medication adherence you may be eligible for a refund of up to four months of fees, provided you are a new user, complete an intake report, and follow the prescribed doses for the full 16 weeks. The homepage advertises this simply as "Weight Loss Guarantee" with no conditions shown.
- Insurance
- Not accepted. Wellorithm is cash-pay only, and its Terms say so. Given that it sells brand-name Wegovy at $899 and Mounjaro at $1,399, anyone with potential coverage should look elsewhere first.
- HSA / FSA
- The site states "HSA/FSA approved!". No seller can approve HSA or FSA eligibility — that is determined by IRS rules and your plan administrator, and reimbursement for compounded medication is not guaranteed. Treat this claim as marketing rather than assurance.
Pricing details worth knowing
- The "$100 off your first month" framing means the headline price is not what you pay from month two. Wellorithm does not publish the ongoing rate alongside it.
- Billing every 28 days produces thirteen charges a year. At $247/month that is roughly $3,211 rather than $2,964.
- Brand-name pricing is far above the manufacturers' own. Novo Nordisk sells Wegovy direct at $199/month for the pen; Eli Lilly sells Zepbound self-pay from $299/month.
- "HSA/FSA approved!" is not something a seller can determine. Eligibility is set by IRS rules and your plan administrator.
- The service is cash-pay and the Terms state insurance is not accepted.
Prices change. Every figure above was taken from Wellorithm's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- Discloses on its homepage that compounded medications have not been reviewed or approved by the FDA
- Correctly labels Wegovy, Ozempic, Mounjaro and Zepbound as the FDA-approved products they are
- Publishes a price for every product rather than hiding them behind an intake form
- The weight-loss guarantee in the Terms has real, stated criteria — 10% at 16 weeks, up to four months of fees
- Oral dissolving tablet options as well as injections
- A published phone number and 24/7 support offer
Cons
- Advertises an 18% average weight loss and that "93% kept the weight off for good" on a stated evidence base of six months of its own patient data
- Attributes "17% increased muscle" to a patient, contrary to the evidence that GLP-1s cause lean mass loss
- Claims "6x more weight loss than exercise and diet alone" and "9/10 Patients call it the most effective treatment to date" with no source
- Footer address appears not to exist — a German address with a Munich postcode, while the Terms call the company Miami-based
- "No membership or hidden fees" is contradicted by the 28-day membership billing in its own Terms
- Billing every 28 days means thirteen charges a year, not twelve
- Payments are non-refundable once processed
- No named physician, medical director or medical group anywhere on the site
- No compounding pharmacy named; no lab requirements published
- Brand-name prices four to seven times the manufacturers' own direct-pay prices
- "HSA/FSA approved!" is not a claim a seller can make
Who Wellorithm May Be Best For
We would not recommend Wellorithm to anyone over the alternatives below.
Limitations
The efficacy claims are the reason to stop here. In February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, followed by 25 more in June 2026 which the agency said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. We have no evidence that Wellorithm has received one. We are pointing at the category of claim, which is squarely what that enforcement concerns.
For context on the numbers: semaglutide produced about 15% of body weight over 68 weeks in STEP 1, and the highest tirzepatide dose about 21% at 72 weeks in SURMOUNT-1. An advertised 18% average at six months from compounded versions, with 93% maintenance, would be a better result than either pivotal trial.
If you want brand-name medication, buy it from the manufacturer. Wegovy is $899 here and $199/month direct from NovoCare Pharmacy; Zepbound is $1,199 here and from $299/month at LillyDirect.
If you proceed anyway, screenshot the ongoing price at checkout, note that billing recurs every 28 days, and get the guarantee terms in writing before paying — the conditions in the Terms are considerably narrower than the homepage badge implies.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Wellorithm — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Wellorithm
NovoCare Pharmacy
Brand-name Wegovy direct from Novo Nordisk at $199/mo for the pen, against $899 here
Read review →LillyDirect
Zepbound self-pay from $299/mo direct from Eli Lilly, with every dose priced publicly
Read review →Henry Meds
If you want compounded medication — established, with named policies and no unsupportable efficacy claims
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Wellorithm for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
Is Wellorithm legitimate?
We cannot tell you it is, and we would not use it. It has a working site, published prices, a phone number and terms with real detail in them. But its Terms and Privacy Policy describe it as "a Miami-based company" while every page footer gives a German address — 785 15h Street, Office 478, Berlin, De 81566 — with a postcode that belongs to Munich and a malformed street name. It names no physician, no medical director and no compounding pharmacy. For a company taking your money, your medical history and your prescription, that is not enough.
Are Wellorithm's weight loss claims realistic?
No. The site advertises an 18% average weight loss, that "93% kept the weight off for good", "6x more weight loss than exercise and diet alone", and a potential 6.5-inch waist reduction, all footnoted to "Data based on Wellorithm patients over their first 6 months of treatment". Six months of data cannot establish that anyone kept weight off for good. For comparison, semaglutide produced around 15% over 68 weeks in STEP 1 and the top tirzepatide dose around 21% at 72 weeks in SURMOUNT-1 — so the advertised figure would beat both pivotal trials, at half the duration, using compounded versions.
How much does Wellorithm actually cost?
More than the advertised figure. Compounded semaglutide is listed from $147/month and tirzepatide from $249/month, but both carry "$100 off your first month", so those are introductory prices and the ongoing rate is not published beside them. Billing recurs every 28 days rather than monthly, which is thirteen charges a year. Brand-name products are $899 for Wegovy, $1,199 for Ozempic and Zepbound, and $1,399 for Mounjaro.
Does the Wellorithm weight loss guarantee mean anything?
It has real terms, which is more than many such badges, but they are narrower than the homepage suggests. Under the Terms you may be eligible for a refund of up to four months of fees if you do not lose at least 10% of your baseline weight after 16 weeks — provided you are a new user, complete an intake report, and adhere to the prescribed doses for the full 16 weeks. The homepage shows only the words "Weight Loss Guarantee". Get the conditions confirmed in writing before you rely on them.
Can I get a refund from Wellorithm?
Outside the weight-loss guarantee, no. The Terms state that payments are non-refundable once processed. You can cancel at any time by email, but the current cycle is not refunded — and with 28-day billing, the cycle you are in can have up to four weeks left to run.
Who should not use Wellorithm?
On the evidence above, we would say most people. Anyone who wants brand-name medication should buy it from NovoCare Pharmacy or LillyDirect at a fraction of the price. Anyone who wants compounded medication has better-documented options. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis — and a two-minute quiz reviewed by an unnamed clinician is a thin basis on which to establish that.
The Verdict
Wellorithm sells compounded semaglutide and tirzepatide from $147 and $249 a month, alongside brand-name GLP-1s at $899 to $1,399. Its marketing makes efficacy claims we cannot see any way to support, its footer address does not appear to be real, and "No membership or hidden fees" is contradicted by the 28-day membership billing in its own Terms.
Opens Wellorithm's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Wellorithm stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Wellorithm's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Wellorithm does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- wellorithm.com/campaign-7 — "Starting at $147" compounded semaglutide injection and ODT, "Starting at $249" compounded tirzepatide injection and ODT, each "Enjoy $100 off your first month"; Wegovy $899, Ozempic $1,199, Zepbound $1,199, Mounjaro $1,399; NAD+ and Sermorelin from $150; "No membership or hidden fees!"; "HSA/FSA approved!"; "Weight Loss Guarantee" (checked August 7, 2026)
- wellorithm.com/campaign-7 — "Lose an average of 18% of your body weight", "93% kept the weight off for good", "6x more weight loss than exercise and diet alone", "9/10 Patients call it the most effective treatment to date", "6.5″ Potential waist reduction", footnoted "* Data based on Wellorithm patients over their first 6 months of treatment"; "We will fix your broken metabolism"; "Join more than 100,000 Wellorithm patients"; patient cards claiming "17% increased muscle", "65% less cravings" and "55% sleep improvement"
- wellorithm.com — "Serving All 50 States", "2-minute quiz to get approved effortlessly", "100% Customer Satisfaction", "Licensed doctors across the United States"; disclosure that "Compounded medications have not been reviewed or approved by the FDA"; footer address "785 15h Street, Office 478, Berlin, De 81566"
- wellorithm.com/terms-conditions — describes Wellorithm as "a Miami-based company"; membership fees "billed every 28 days"; "payments are non-refundable once processed"; cancellation by email with the current cycle not refunded; weight-loss guarantee of up to four months of fees if the user does not lose at least 10% of baseline weight after 16 weeks of medication adherence, subject to being a new user, completing an intake report and following prescribed doses; individual arbitration; governing law New York; 30 days’ notice for discontinuation; insurance not accepted
- wellorithm.com/privacy-policy — also describes Wellorithm as "a Miami-based company", while carrying the same German footer address
- novocare-pharmacy and lillydirect entries in this review set — Wegovy pen $199/mo direct from Novo Nordisk; Zepbound self-pay from $299/mo direct from Eli Lilly, for comparison against Wellorithm’s brand-name pricing
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.